Related Experiment Video
Updated: Apr 30, 2026
High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Molecular pathways: turning proteasomal protein degradation into a unique treatment approach
Sebastian Stintzing1, Heinz-Josef Lenz2
1Authors' Affiliation: USC/Norris Comprehensive Cancer Center, Keck School of Medicine, Sharon Carpenter Laboratory, Los Angeles, California.
Abstract:
Cancer treatment regimens have evolved from single cytotoxic substances affecting all proliferative tissues toward antibodies and kinase inhibitors targeting tumor-specific pathways. Treatment efficacy and cancer survival have improved overall, and side effects have become less frequent. The ubiquitin-proteasome system-mediated proteasomal protein degradation is the most critical pathway to regulate the quantity of signal proteins involved in carcinogenesis and tumor progression. These processes are, as well as protein recycling, highly regulated and offer targets for biomarker and drug development. Unspecific proteasome inhibitors such as bortezomib and carfilzomib have shown clinical efficacy and are approved for clinical use. Inhibitors of more substrate-specific enzymes of degradation processes are being developed and are now in early clinical trials. The novel compounds focus on the degradation of key regulatory proteins such as p53, p27(Kip1), and ß-catenin, and inhibitors specific for growth factor receptor kinase turnover are in preclinical testing.
Insights
Cancer therapies now target specific pathways, improving efficacy and reducing side effects. The ubiquitin-proteasome system offers new targets for developing more precise cancer drugs.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer treatments have shifted from broad cytotoxic agents to targeted therapies like antibodies and kinase inhibitors.
- Improved treatment efficacy and survival rates are observed, with a decrease in adverse side effects.
- The ubiquitin-proteasome system is crucial for regulating proteins involved in cancer development and progression.
Purpose of the Study:
- To review the evolution of cancer treatment strategies.
- To highlight the ubiquitin-proteasome system as a key target for novel drug development.
- To discuss the progression of proteasome inhibitors from unspecific to substrate-specific agents.
Main Methods:
- Review of current literature on cancer therapeutics and molecular pathways.
- Analysis of the role of the ubiquitin-proteasome system in carcinogenesis.
- Examination of existing and emerging proteasome inhibitor drugs.
Main Results:
- Unspecific proteasome inhibitors (bortezomib, carfilzomib) are clinically approved and effective.
- Development of substrate-specific inhibitors targeting key regulatory proteins (p53, p27Kip1, ß-catenin) is underway.
- Preclinical testing is ongoing for inhibitors targeting growth factor receptor kinase turnover.
Conclusions:
- Targeted therapies and modulation of protein degradation pathways represent the future of cancer treatment.
- The ubiquitin-proteasome system offers significant potential for developing next-generation cancer biomarkers and drugs.
- Further research into substrate-specific inhibitors promises enhanced efficacy and reduced toxicity in cancer therapy.
Related Concept Videos
02:18The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
01:13The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:58Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
02:58Regulated Protein Degradation
01:17The Proteasome Structure
The proteasome is an...
02:11Proteins: From Genes to Degradation